INTRODUCTION
Cervical artery dissection is a common cause of stroke in young adults with an incidence of 2.6-2.9 per 100,000 patients. It is classified based on the artery involved (vertebral vs. carotid) and location (intracranial vs. extracranial). The most common dissection is an extracranial internal carotid artery (ICA) dissection. Dissection is defined by the separation of arterial wall layers, which creates a false lumen allowing blood to escape and expand. This may result from head and neck trauma or can occur spontaneously or secondary to genetic connective tissue or vascular disorders, such as Ehlers-Danlos syndrome, Marfan syndrome and most commonly fibromuscular dysplasia. Neurologic symptoms arise as a result of thromboembolism and hypoperfusion causing cerebral ischemia. Mass effect of the dissecting artery may also cause local nerve root compression resulting in Horner's syndrome.
CASE REPORT
We present a case of a 30-year-old previously healthy male who presented to the emergency department (ED) with complaints of a new gradual onset left-sided throbbing headache with transient right-sided paresthesias and a right hemianopsia that occurred at rest. There was no associated weakness or other focal neurologic deficits. His symptoms spontaneously resolved on arrival to the ED. He reported recent chiropractic manipulation of the cervical spine one Naval Medical Center, Department of Emergency Medicine, San Diego, California Scripps Mercy, Department of Emergency Medicine, San Diego, California * † week prior to presentation. He also noted remote trauma, having been involved in a motorcycle accident approximately nine months prior sustaining a left clavicle fracture that was initially treated non-operatively. However, he required surgical repair due to malunion. At the time of ED presentation, his neurologic exam was unremarkable.
Non-contrast head computerized tomography (CT) was unremarkable. CT angiography (CTA) of the head and neck was performed because of his reported transient neurologic deficits, and it revealed a left cervical ICA dissection 1.7cm from the carotid bifurcation extending to the base of the skull and a 7mm pseudoaneurysm near the proximal aspect of the dissection (Image 1 and 2). Both neurology and neurosurgery were consulted, and there was no consensus on stroke prophylaxis.
The patient was ultimately started on oral aspirin 325mg daily and atorvastatin 80mg daily and admitted to the medical intensive care unit. Magnetic resonance imaging (MRI) with angiography of the head and neck were subsequently performed revealing no large perfusion defects (Image 3 and 4). Angiogram was performed, further demonstrating the left ICA dissection and pseudoaneurysm. Two ICA stents were placed given concerns for the patient's long-term risk for stroke. He was then transitioned to dual antiplatelet therapy with clopidogrel and aspirin and discharged home. The patient had follow-up weeks later and remained asymptomatic. 
DISCUSSION
Cervical artery dissection usually presents with a combination of transient ischemic attack or ischemic stroke, headache, and neck pain. Reportedly, 56% of patients present with symptoms of cerebral ischemia and 25% with Horner's syndrome. Head and neck pain are the most common symptoms of cervical artery dissection, found in 60%-90% of cases, but only 20% have sudden thunderclap headaches. Other presentations include tinnitus and scalp tenderness. The mean age of occurrence is approximately 45 years with a slightly higher male predominance (53-57%). Risk of recurrent stroke is 2-3%, typically occurring in the first two weeks after dissection.
Associations between cervical spine manipulation (CSM) and cervical artery dissection have been described in case reports and case control studies. In 2016, a systematic review and meta-analysis was published that concluded the quality of data on this relationship is low and there is no convincing evidence to support a causal link between CSM and cervical artery dissection. It concluded that associations were likely biased by the strong possibility that patients with early dissection-related symptoms, such as neck pain, seek chiropractic care prior to developing a stroke. With these studies in mind the American Heart Association and American Stroke Association (AHA/ASA) released a scientific statement, updated in November 2016, that while incidence of cervical artery dissection in CSM is probably low and causality remains difficult to prove, physicians should consider the possibility of cervical artery dissection in this patient population and inform patients of the possible connection.
On presentation, standard approaches to management should be performed including blood pressure regulation, fluid administration, glycemic control, and other correction of metabolic derangements, with the primary goal in treatment of cervical artery dissection to prevent stroke. Treatment is sometimes started in the ED with antithrombotic or anticoagulation medication. However, research is limited regarding the efficacy of one therapy over the other. In 2010, a Cochrane review showed no randomized control trials comparing either antiplatelet or anticoagulant drugs with control or directly comparing them to each other, concluding that there was no evidence to support their routine use or any significant difference 
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Cervical Artery Dissection and Choosing Appropriate Therapy in efficacy in extracranial cervical artery dissection. In 2015, a meta-analysis of 38 (non-randomized) studies showed no significant difference between antiplatelet versus anticoagulation therapy with respect to death or disability. The Cervical Artery Dissection in Stroke Study (CADISS Trial) randomized 250 patients within seven days of stroke onset to antiplatelet or anticoagulation therapy, which showed no difference in stroke risk. A major limitation of this study was that it was underpowered given the low stroke recurrence rates in both groups. It is estimated that a trial with adequate power to show any potential difference would require approximately 4,800 patients in each treatment group. Conducting a study requiring such a large cohort with its low recurrence rates is impractical. The AHA 2011 guidelines state that the relative efficacy of anticoagulation versus antiplatelet therapy is unknown, and antithrombotic treatment was recommended for three to six months for those who sustain a stroke or transient ischemic attack. The same year, an executive summary released from the American College of Cardiology Foundation and the ASA made Class IIa recommendations to initiate treatment with anticoagulation followed by antiplatelet therapy. 
